Loading...
Diffusion Pharmaceuticals Inc.
DFFN•NASDAQ
HealthcareBiotechnology
$4.40
$0.41(10.28%)
Diffusion Pharmaceuticals Inc. (DFFN) Company Profile & Overview
Explore Diffusion Pharmaceuticals Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Diffusion Pharmaceuticals Inc. (DFFN) Company Profile & Overview
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
SectorHealthcare
IndustryBiotechnology
CEODr. Robert J. Cobuzzi Jr., Ph.D.
Contact Information
Company Facts
13 Employees
IPO DateMay 23, 2008
CountryUS